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Chronic	renal	disease	is	a	pathologic	process	induced	by	 multiple	 etiologies,	 which	 cause	 unstoppable	
reduction	 of	 the	 number	 and	 function	 of	 nephrons,	
which	 leads	 to	 end	 stage	 renal	 disease	 (ESRD).	
This	 disease	 results	 in	 dependence	 of	 the	 patients	 to	
















of	 the	 third	 century.3	 In	 Iran,	 the	 major	 causes	 of	
kidney	failure	are	diabetes	mellitus	(DM),	hypertension	
(HTN),	 glumerulonephritis	 (GN),	 and	 urologic	
problems	 (UP);	 and	 the	 survival	 of	 ESRD	 patients	 is	
normally	lower	than	common	people.4	There	are	many	
new	 established	 dialysis	 centers	 in	 Iran,	 and	 which	
are	mostly	state	centers.	The	number	of	dialysis		units	




government	 or	 the	 insurance	 paid	 for	 their	 charges).	
Most	of	these	patients	use	the	facility	regularly,	and	some	
have	no	regular	dialysis	due	to	the	shortage	of	facilities;	
the	 distance	 between	 patients	 and	 the	 dialysis	 center,	
















who	 underwent	 kidney	 transplantation	 and	 lost	 their	
follow	 up	 were	 not	 included	 in	 this	 study.	 Of	 136	
patients,	49	died	during	the	study	period.
Five	percent	have	missing	values	such	as	birth	year,	






















patients.	 The	 survival	 proportion	 in	 20,	 40,	 50,	 and	
60	 years	 old	patients	was	 99.2%,	93.2%,	82.3%	and	
60.6%.	This	proportion	for	≥70	year	old	patients	was	
<37.1%.	The	mean	survival	was	64.5	(SE=1.76)	years	




was	 found	 between	 survival	 and	 gender	 (male	 66.1	
and	 female	62.3	years,	p=0.284),	 the	causes	of	ESRD	




and	 the	 survival	 of	 those	who	have	more	dialysis	was	
more	 than	the	others.	Also,	 the	 survival	of	 those	who	
use	 polysulfan	 membrane	 or	 bicarbonate	 solution	




important	 cause	 of	 ESRD	 was	 DM,	 which	 is	 similar	
to	another	study	in	Saudi	Arabia,5	while	no	significant	
relationship	between	the	different	causes	of	ESRD	and	
the	 patients’	 survival	 (p=0.367).6	 	 Also,	 in	 a	 study	 in	
Syria,7	 they	found	that	 the	causes	of	ESRD	are	HTN	







et	 al,9	which	 proved	 that	 female	 patients	 had	 a	 lower	
survival	than	males.	In	this	study,	there	was	no	significant	












and	 the	 dialysis	 membrane	 and	 solution.	 It	 was	 also	
shown	 in	 another	 study	 in	 Shahrood6	 that	 unsuitable	
membrane	 leads	 to	 an	 inefficient	 dialysis.	 Therefore,	
in	 choosing	 the	 solution	 and	 membrane	 for	 dialysis,	





is	 significantly	 lower	 than	 others.5	 Therefore,	 patients	
need	to	learn	the	importance	of	completing	treatment,	
and	the	necessary	facilities	to	visit	the	center	regularly	
Survival	analysis	of	dialysis	patients	in	Iran	... Roudbari et al
Table 1 - The	frequency	of	total	and	dead	patients	together	with	the	mean,	SE	and	the	result	of	Log	rank	test	on	the	
factors	associated	with	survival	time	in	136	hemodialysis	patients	in	Zahedan,	Iran.	
Variables Frequency Number of 
death
Mean ± SE of survival 
(years)
Log rank test 
p-value
Number	of	monthly	dialysis* 												7.9	±	15.33 0.001
1-4 13 8 			57.8	±	4.75
5-8 56 28 						58	±	2.11
9-12 59 11 			71.9	±	2.78
Kind of membranes* 0.002
Polysulfon 115 29 		67.2	±	2.13
Hemophan 13 13 			55.3	±	3.42
Both 4 4 	62.7	±	7.2
Type of solution* 0.024
Bicarbonate 37 17 			56.9	±	2.47
Acetate 55 14 			68.6	±	2.67
Both 36 10 	64.4	±	3.1
Age*       50	±	2.36 0.000
≤29 19 4 			27.8	±	0.54
30-39 14 3 			37.9	±	0.61
40-49 27 8 			47.3	±	0.31
50-59 36 14 			56.5	±	0.58
60-69 26 11 			66.2	±	0.78
70-79 10 7 			78.4	±	1.73
*There	were	some	missing	values,	SE	-	standard	error
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should	 be	 provided	 for	 them.	 Previous	 studies,5,6	
showed	that	there	is	a	significant	relationship	between	
dialysis	and	its	duration	with	survival.	Therefore,	those	
who	 have	 dialysis	 with	 incomplete	 duration	 <3	 times	




of	 the	 dialysis	 units,	 introducing	 suitable	 education	
for	the	patients	and	their	family	regarding	the	disease,	
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